Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Clermont-Ferrand
About this trial
The investigators propose to carry out a national retrospective study to collect epidemiological, biological, clinical and therapeutic data on microsporidiosis among heart transplant patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
heart transplant patients diagnosed with intestinal microsporidiosis
diagnosis made before December 31, 2024 in France (metropolitan France and overseas territories)
Disqualifiers
None
Trial population
Heart transplant patients with microsporidiosis
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Demographic data: age
expressed in years old
Time frame
1 year2
Demographic data: sex
choice between: male/female
Time frame
1 year3
Time between transplant and microsporidiosis
expressed in days, or years if \>365 days
Time frame
1 year4
At diagnosis: number of days since the onset of symptoms
expressed in number of days
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov